Effects of Cilazaprilat and Enalaprilat on Experimental Dermatitis in Guinea Pigs
- 1 May 1991
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 68 (5), 404-407
- https://doi.org/10.1111/j.1600-0773.1991.tb01261.x
Abstract
Two non-sulfur containing ACE-inhibitors were tested concerning their local effect on experimental dermatitis in ovalbumin-sensitized guinea pigs. Enalaprilat but not cilazaprilat potentiated the ovalbumin-evoked inflammatory response. Furthermore, enalaprilat clearly enhanced the erythema evoked by substance P, whereas cilazaprilat did not. Concerning, the bradykinin-evoked erythema, enalaprilat significantly potentiated the response, whereas cilazaprilat only caused a slight increase. Our results suggest that different affinities for peptidases involved in degradation of inflammatory peptides can explain differences between the pro-inflammatory properties of enalaprilat and cilazaprilat.Keywords
This publication has 13 references indexed in Scilit:
- Angiotensin-Converting Enzyme Inhibitors and Their Influence on Inflammation, Bronchial Reactivity and CoughDrug Safety, 1989
- Potentiation of inflammatory reactions in guinea-pig skin by an angiotensin converting enzyme inhibitor (MK 422)European Journal of Pharmacology, 1987
- Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapyAmerican Journal Of Medicine, 1986
- Clinical Pharmacology of the ACE InhibitorsDrugs, 1986
- Clinical applications of angiotensin-converting enzyme inhibitorsAmerican Journal Of Medicine, 1984
- Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidasePeptides, 1984
- CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?The Lancet, 1984
- Substance P degradation by rat brain peptidases: Inhibition bY SQ 20881Biochemical Pharmacology, 1979
- MECHANISMS OF THE FLARE REACTION IN HUMAN SKINJournal of Investigative Dermatology, 1977
- A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACABritish Journal of Pharmacology and Chemotherapy, 1965